investigate second generation PhpCs by varying the position
and nature of substitution on the phenyl ring. It was our
intention in the design that the bases remain capable of
forming an additional hydrogen bond to guanine while
fluorometrically responding on the state of hybridization
(Figure 2).
We first decided to synthesize the ortho-substituted
analogue with a three-carbon chain, mopPhpC (Figure 2a),
in order to establish if the ethyl linker (moePhpC) was too
short. Further, we reasoned that ortho-substituted PhpCs may
form an undesirable secondary repulsive interaction between
the oxygen on the phenyl ring and the O6 of guanine. The
meta-substituted PhpCs (mmePhpC and mmpPhpC, Figure
2b) were synthesized in order to determine if this substitution
was more favorable, potentially by relief of secondary
repulsive interactions. Finally, we chose the nucleobase with
the highest affinity toward both DNA and RNA as a good
candidate for derivatiztion to the guanidinium group. Instal-
lation of the guanidinium group on the mmePhpC scaffold
holds the potenial to further increase the binding affinity
through dual O6- and N7-Hoogsteen hydrogen bonds (Figure
2c).
Figure 1. Previously studied cytosine analogues, based on the
phenoxazine and PhpC nucleobases, capable of forming a fourth
hydrogen bond to guanine: (a) phenoxazine-based G-clamp and (b)
phenylpyrrolocytosine-based boPhpC.
and G-clamp nucleobases continue to be modified and exploited
in various applications.8
We have recently designed a novel intrinsically fluorescent
cytosine analogue based on PhpC, termed boPhpC9 (Figure
1b).
Our previous work indicated that the boPhpC nucleobase
also formed a fourth hydrogen bond to guanine, thereby
increasing binding affinity, but also fluorimetrically reported
on PNA/DNA hybridization.9 This dual behavior places
boPhpC and its analogues in a unique class of molecules.
While studying the hybridization properties of moePhpC
(Figure 2a), we noticed significantly greater stabilization of
The required alkyne, 2, for the synthesis of mopPhpC was
prepared by treating 2-iodophenol with tert-butyl 2-bro-
mopropylcarbamate to give 1 which was subjected to
Sonogashira reaction conditions and TMS removal to give
the terminal alkyne 2 (Scheme 1a). Similarly, the synthesis
Scheme 1. Synthesis of Alkynes 2, 5, and 6
Figure 2. Structures of modified PhpCs designed to engage guanine
with an additional hydrogen bond. (a) Previously studied moePhpC
and newly synthesized mopPhpC; (b) meta-substituted PhpCs
mmePhpC (n ) 1) and mmpPhpC (n ) 2); (c) proposed interaction
of guanidino-PhpC (mmguaPhpC) with guanine.
of alkynes 5 and 6 was accomplished by treating 3-bro-
mophenol with tert-butyl 2-bromoethylcarbamate or tert-
butyl 2-bromopropylcarbamate to give 3 or4, which were
subjected to Sonogashira reaction conditions and TMS
removal to give alkynes 5 and 6 (Scheme 1b).
a PNA/DNA duplex over a PNA/RNA duplex of the same
sequence. Furthermore, the flanking nucleobases in PNAs
containing moePhpC would affect the overall duplex stability.
In a recent study, an unusual sequence-dependent behavior
has also been observed with the G-clamp in both DNA and
PNA.10
Alkynes 2, 5, or 6 and ethyl (N4-benzoyl-5-iodocytosin-
1-yl)acetate6a were subjected to a one-pot Sonogashira cross-
In order to address the lower binding affinity toward RNA
and the sequence-dependent behavior, we have decided to
(8) (a) Flanagan, W. M.; Wolf, J. J.; Olson, P.; Grant, D.; Lin, K.-Y;
Wagner, R. W; Matteucci, M. D. Proc. Natl. Acad. Sci. U.S.A. 1999, 96,
3513–3518. (b) Maier, M. A.; Leeds, J. M.; Balow, G.; Springer, R. H.;
Bharadwaj, R.; Manoharan, M. Biochemistry 2002, 41, 1323–1327. (c)
Nakagawa, O.; Ono, S.; Li, Z.; Tsujimoto, A.; Sasaki, S. Angew. Chem.,
Int. Ed. 2007, 46, 1–5. (d) Barhate, N.; Cekan, P.; Massey, A. P.; Sigurdsson,
S. Th. Angew. Chem., Int. Ed. 2007, 46, 2655–2658.
(7) (a) Lin, K.-Y.; Matteucci, M. D. J. Am. Chem. Soc. 1998, 120, 8531–
8532. (b) Wilds, C. J.; Maier, M. A.; Tereshko, V.; (c) Manoharan, M.;
Egli, M. Angew. Chem., Int. Ed. 2002, 41, 115–117. (d) Wilds, C. J; Maier,
M. A.; Manoharan, M.; Egli, M. HelV. Chim. Acta 2003, 86, 966–978. (e)
Ausin, C.; Ortega, J.-A.; Robles, J.; Grandas, A.; Pedroso, E. Org. Lett.
2002, 4, 4073–4075. (f) Rajeev, K. G.; Maier, M. A.; Lesnik, E. A.;
Manoharan, M. Org. Lett. 2002, 4, 4395–4398. (g) Chenna, V.; Rapireddy,
S.; Sahu, B.; Ausin, C.; Pedroso, E.; Ly, D. H. ChemBioChem 2008, 9,
2388–2391.
(9) (a) Wojciechowski, F.; Hudson, R. H. E. J. Am. Chem. Soc. 2008,
130, 12574–12575. (b) Wojciechowski, F.; Hudson, R. H. E. Nucleic Acids
Sym. Ser (Oxford) 2008, 52, 401–402.
(10) Ortega, J.-A.; Blas, J. R.; Orozco, M.; Grandas, A.; Pedroso, E.;
Robles, J. Org. Lett. 2007, 9, 4503–4506.
Org. Lett., Vol. 11, No. 21, 2009
4879